Výsledky vyhledávání - Karin Kast

Upřesnit hledání
  1. 1
    Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review

    Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review Autor D. Huber, S. Seitz, Karin Kast, G. Emons, Olaf Ortmann

    Vydáno 2020
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review

    Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review Autor D. Huber, S. Seitz, Karin Kast, Günter Emons, Olaf Ortmann

    Vydáno 2021
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Hereditary Breast and Ovarian Cancer

    Hereditary Breast and Ovarian Cancer Autor Alfons Meindl, Nina Ditsch, Karin Kast, Kerstin Rhiem, Rita K. Schmutzler

    Vydáno 2011
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  4. 4
    MLPA screening in the<i>BRCA1</i>gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases

    MLPA screening in the<i>BRCA1</i>gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases Autor Stefanie Engert, Barbara Wappenschmidt, Beate Betz, Karin Kast, Michael Kutsche, Heide Hellebrand, Timm O. Goecke, Marion Kiechle, Dieter Niederacher, Rita K. Schmutzler, Alfons Meindl

    Vydáno 2008
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Analysis of 30 Putative BRCA1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape In Silico Prediction

    Analysis of 30 Putative BRCA1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape In Silico Prediction Autor Barbara Wappenschmidt, Alexandra Becker, Jan Hauke, Weber Ute, Stefanie Engert, Juliane Köhler, Karin Kast, Norbert Arnold, Kerstin Rhiem, Eric Hahnen, Alfons Meindl, Rita K. Schmutzler

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA

    RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA Autor Christine Wolf, Alexander Rapp, Nicole Berndt, Wolfgang Staroske, Max Schuster, Manuela Dobrick-Mattheuer, Stefanie Kretschmer, N. König, Thomas Kurth, Dagmar Wieczorek, Karin Kast, M. Cristina Cardoso, Claudia Günther, Min Ae Lee‐Kirsch

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study

    The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort s... Autor Kerstin Rhiem, Christoph Engel, Monika Graeser, Silke Zachariae, Karin Kast, Marion Kiechle, Nina Ditsch, Wolfgang Janni, Christoph Mundhenke, Michael Golatta, Dominic Varga, Sabine Preisler-Adams, T. Heinrich, Ulrich Bick, Dorothea Gadzicki, Susanne Briest, Alfons Meindl, Rita K. Schmutzler

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Contralateral Breast Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers

    Contralateral Breast Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Autor Monika Graeser, Christoph Engel, Kerstin Rhiem, Dorothea Gadzicki, Ulrich Bick, Karin Kast, Ursula G. Froster, B. Schlehe, Astrid Bechtold, Norbert Arnold, Sabine Preisler-Adams, Carolin Nestle-Kraemling, Mohammad Zaino, Markus Loeffler, Marion Kiechle, Alfons Meindl, Dominic Varga, Rita K. Schmutzler

    Vydáno 2009
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer

    Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer Autor Olaf Schoffer, Pauline Wimberger, Michael Gerken, Veronika Bierbaum, Christoph Bobeth, M Rößler, Patrik Dröge, Thomas Ruhnke, Christian Günster, Kees Kleihues-van Tol, Theresa Link, Anton Scharl, Elisabeth C. Inwald, Karin Kast, Thomas Papathemelis, Olaf Ortmann, Monika Klinkhammer‐Schalke, Jochen Schmitt

    Vydáno 2024
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial

    Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant trea... Autor Andreas Schneeweiß, Volker Möbus, Hans Tesch, Claus Hanusch, Carsten Denkert, Kristina Lübbe, Jens Huober, Peter Klare, Sherko Kümmel, Michael Untch, Karin Kast, Christian Jackisch, Jörg Thomalla, Barbara Ingold‐Heppner, Jens‐Uwe Blohmer, Mahdi Rezai, Matthias Frank, Knut Engels, Kerstin Rhiem, Peter A. Fasching, Valentina Nekljudova, Gϋnter von Minckwitz, Sibylle Loibl

    Vydáno 2018
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history

    Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history Autor Christoph Engel, Kerstin Rhiem, Eric Hahnen, Sibylle Loibl, Karsten E. Weber, Sabine Seiler, Silke Zachariae, Jan Hauke, Barbara Wappenschmidt, Anke Waha, Britta Blümcke, Marion Kiechle, Alfons Meindl, Dieter Niederacher, Claus R. Bartram, Dorothee Speiser, Brigitte Schlegelberger, Norbert Arnold, Peter Wieacker, Elena Leinert, Andrea Gehrig, Susanne Briest, Karin Kast, Olaf Rieß, Günter Emons, Bernhard H. F. Weber, Jutta Engel, Rita K. Schmutzler

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883)

    Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883) Autor Jan Hauke, Eric Hahnen, Stephanie Schneider, Alexander Reuß, Lisa Richters, Stefan Kommoss, André Heimbach, Frederik Marmé, Sandra Schmidt, Katharina Prieske, Heidrun Gevensleben, Alexander Burges, Julika Borde, Nikolaus de Gregorio, Peter Nürnberg, Ahmed El‐Balat, Hölger Thiele, Felix Hilpert, Janine Altmüller, Werner Meier, Dimo Dietrich, Rainer Kimmig, Birgid Schoemig-Markiefka, Karin Kast, Elena Ioana Braicu, Klaus Baumann, Christian Jackisch, Tjoung‐Won Park‐Simon, Corinna Ernst, Lars Hanker, Jacobus Pfisterer, Andreas Schnelzer, Andreas du Bois, Rita K. Schmutzler, Philipp Harter

    Vydáno 2019
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Prevalence of<i>BRCA1/2</i>germline mutations in 21 401 families with breast and ovarian cancer

    Prevalence of<i>BRCA1/2</i>germline mutations in 21 401 families with breast and ovarian cancer Autor Karin Kast, Kerstin Rhiem, Barbara Wappenschmidt, Eric Hahnen, Jan Hauke, Britta Bluemcke, V Zarghooni, N Herold, Nina Ditsch, Marion Kiechle, Michael Braun, Christine Fischer, Nicola Dikow, Sarah Schott, Nils Rahner, Dieter Niederacher, Tanja Fehm, Andrea Gehrig, Clemens Mueller-Reible, Norbert Arnold, Nicolaì Maass, Guntram Borck, Nikolaus de Gregorio, Caroline Scholz, Bernd Auber, Raymonda Varon-Manteeva, Dorothee Speiser, Judit Horváth, Nadine Lichey, Pauline Wimberger, Sylvia Stark, Ulrike Faust, Bernhard H. F. Weber, Günter Emons, Silke Zachariae, Alfons Meindl, Rita K. Schmutzler, Christoph Engel

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)

    Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1) Autor Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuß, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges, Guido Neidhardt, Nikolaus de Gregorio, Ahmed El‐Balat, Felix Hilpert, Werner Meier, Rainer Kimmig, Karin Kast, Jalid Sehouli, Klaus Baumann, Christian Jackisch, Tjoung‐Won Park‐Simon, Lars Hanker, Sandra Kröber, Jacobus Pfisterer, Heidrun Gevensleben, Andreas Schnelzer, Dimo Dietrich, Tanja Neunhöffer, Mathias Krockenberger, Sara Y. Brucker, Peter Nürnberg, Hölger Thiele, Janine Altmüller, Josefin Lamla, Gabriele Elser, Andreas du Bois, Eric Hahnen, Rita K. Schmutzler

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Breast cancer risk in <i>BRCA1/2</i> mutation carriers and noncarriers under prospective intensified surveillance

    Breast cancer risk in <i>BRCA1/2</i> mutation carriers and noncarriers under prospective intensified surveillance Autor Christoph Engel, Christine Fischer, Silke Zachariae, Karolin Bucksch, Kerstin Rhiem, J Giesecke, N Herold, Barbara Wappenschmidt, Verena Hübbel, Monika Maringa, S Reichstein-Gnielinski, Eric Hahnen, Claus R. Bartram, Nicola Dikow, Sarah Schott, Dorothee Speiser, Denise Horn, Eva Maria Fallenberg, Marion Kiechle, Anne S. Quante, Anne‐Sophie Vesper, Tanja Fehm, Christoph Mundhenke, Norbert Arnold, Elena Leinert, Walter Just, Ulrike Siebers‐Renelt, Stefanie Weigel, Andrea Gehrig, Achim Wöckel, Brigitte Schlegelberger, Stefanie Pertschy, Karin Kast, Pauline Wimberger, Susanne Briest, Markus Loeffler, Ulrich Bick, Rita K. Schmutzler

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study

    Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study Autor Lieske H. Schrijver, Håkan Olsson, Kelly‐Anne Phillips, Mary Beth Terry, David E. Goldgar, Karin Kast, Christoph Engel, Thea M. Mooij, Julian Adlard, Daniel Barrowdale, Rosemarie Davidson, Rosalind A. Eeles, Ian O. Ellis, D. Gareth Evans, Debra Frost, Louise Izatt, Mary Porteous, Lucy Side, Lisa Walker, Pascaline Berthet, Valérie Bonadona, Dominique Leroux, Emmanuelle Mouret‐Fourme, Laurence Vénat-Bouvet, Saundra S. Buys, Melissa C. Southey, Esther M. John, Wendy K. Chung, Mary B. Daly, Anita Bane, Christi J. van Asperen, E. Gómez, Marian J.E. Mourits, Theo A.M. van Os, Marie-José Roos-Blom, Michael L Friedlander, Sue‐Anne McLachlan, Christian F. Singer, Yen Y. Tan, Lenka Foretová, Marie Navrátilová, Anne‐Marie Gerdes, Trinidad Caldés, Jacques Simard, Edith Oláh, Anna Jakubowska, Brita Arver, Ana Osório, Catherine Noguès, Nadine Andrieu, Douglas F. Easton, Flora E. van Leeuwen, John L. Hopper, Roger L. Milne, Antonis C. Antoniou, Matti A. Rookus

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

    Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers Autor Nasim Mavaddat, Antonis C. Antoniou, Thea M. Mooij, Maartje J. Hooning, Bernadette A. M. Heemskerk‐Gerritsen, Catherine Noguès, Marion Gauthier‐Villars, Olivier Caron, Paul Gesta, Pascal Pujol, Alain Lortholary, Daniel Barrowdale, Debra Frost, D. Gareth Evans, Louise Izatt, Julian Adlard, Rosalind A. Eeles, Carole Brewer, Marc Tischkowitz, Alex Henderson, Jackie Cook, Diana Eccles, Klaartje van Engelen, Marian J.E. Mourits, Margreet G.E.M. Ausems, Linetta B. Koppert, John L. Hopper, Esther M. John, Wendy K. Chung, Irene L. Andrulis, Mary B. Daly, Saundra S. Buys, Javier Benı́tez, Trinidad Caldés, Anna Jakubowska, Jacques Simard, Christian F. Singer, Yen Y. Tan, Edith Oláh, Marie Navrátilová, Lenka Foretová, Anne‐Marie Gerdes, Marie-José Roos-Blom, Flora E. van Leeuwen, Brita Arver, Håkan Olsson, Rita K. Schmutzler, Christoph Engel, Karin Kast, Kelly‐Anne Phillips, Mary Beth Terry, Roger L. Milne, David E. Goldgar, Matti A. Rookus, Nadine Andrieu, Douglas F. Easton

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i>

    Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i> Autor Xin Yang, Honglin Song, Goska Leslie, Christoph Engel, Eric Hahnen, Bernd Auber, Judit Horváth, Karin Kast, Dieter Niederacher, Clare Turnbull, Richard S. Houlston, Helen Hanson, Chey Loveday, Jill S. Dolinsky, Holly LaDuca, Susan J. Ramus, Usha Menon, Adam N. Rosenthal, Ian Jacobs, Simon A. Gayther, Ed Dicks, Heli Nevanlinna, Kristiina Aittomäki, Liisa M. Pelttari, Hans Ehrencrona, Åke Borg, Anders Kvist, Bárbara Rivera, Thomas van Overeem Hansen, Malene Djursby, Andrew Lee, Joe Dennis, David D.L. Bowtell, Nadia Traficante, Orland Dı́ez, Judith Balmañà, Stephen B. Gruber, Georgia Chenevix‐Trench, kConFab Investigators, Allan Jensen, Susanne K. Kjær, Estrid Høgdall, Laurent Castéra, Judy E. Garber, Ramūnas Janavičius, Ana Osório, Lisa Golmard, Ana Vega, Fergus J. Couch, Mark E. Robson, Jacek Gronwald, Susan M. Domchek, Julie O. Culver, Miguel de la Hoya, Douglas F. Easton, William D. Foulkes, Marc Tischkowitz, Alfons Meindl, Rita K. Schmutzler, Paul D.P. Pharoah, Antonis C. Antoniou

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Risks of Breast, Ovarian, and Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers

    Risks of Breast, Ovarian, and Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Autor Karoline Kuchenbaecker, John L. Hopper, Daniel R. Barnes, Kelly‐Anne Phillips, Thea M. Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E. van Leeuwen, Roger L. Milne, Nadine Andrieu, David E. Goldgar, Mary Beth Terry, Matti A. Rookus, Douglas F. Easton, Antonis C. Antoniou, Lesley McGuffog, D. Gareth Evans, Daniel Barrowdale, Debra Frost, Julian Adlard, Kai-Ren Ong, Louise Izatt, Marc Tischkowitz, Rosalind A. Eeles, Rosemarie Davidson, Shirley Hodgson, Ian O. Ellis, Catherine Noguès, Christine Lasset, Dominique Stoppa‐Lyonnet, Jean‐Pierre Fricker, Laurence Faivre, Pascaline Berthet, Maartje J. Hooning, Lizet E. van der Kolk, Carolien M. Kets, Muriel A. Adank, Esther M. John, Wendy K. Chung, Irene L. Andrulis, Melissa C. Southey, Mary B. Daly, Saundra S. Buys, Ana Osório, Christoph Engel, Karin Kast, Rita K. Schmutzler, Trinidad Caldés, Anna Jakubowska, Jacques Simard, Michael Friedlander, Sue‐Anne McLachlan, Eva Macháčková, Lenka Foretová, Yen Y. Tan, Christian F. Singer, Edith Oláh, Anne‐Marie Gerdes, Brita Arver, Håkan Olsson

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)

    Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto) Autor Gϋnter von Minckwitz, Sibylle Loibl, Michael Untch, Holger Eidtmann, Mahdi Rezai, Peter A. Fasching, Hans Tesch, Holm Eggemann, Iris Schrader, K. Kittel, Claus Hanusch, Jens Huober, Christine Solbach, Christian Jackisch, G. Kunz, Jens‐Uwe Blohmer, Maik Hauschild, Tanja Fehm, Valentina Nekljudova, B. Gerber, K. Gnauert, Bernhard Heinrich, T. Prätz, U. Groh, H. Tanzer, C. Villena, A.H. Tulusan, B Liedtke, Jens‐Uwe Blohmer, K. Kittel, Christine Mau, Jochem Potenberg, Jörg Schilling, Marianne Just, Erich Weiß, Ute Bückner, M Wolfgarten, Ralf Lorenz, Gabriele Doering, Susanne Maria Feidicker, Petra Krabisch, U. Deichert, Doris Augustin, G. Kunz, Karin Kast, Gϋnter von Minckwitz, C. Nestle-Krämling, Mahdi Rezai, C. Höß, Jürgen Terhaag, Peter A. Fasching, Peter Staib, Bahriye Aktas, Thorsten Kühn, F Khandan, Volker Möbus, Christine Solbach, Hans Tesch, Elmar Stickeler, G. Heinrich, H. Wagner, Ahmed Abdallah, T. Dewitz, G. Emons, Antje Belau, Volker Rethwisch, Tilmann Lantzsch, Christoph Thomssen, Ute Marie Mattner, A. Nugent, Volkmar Müller, Thomas Noesselt, Frank Holms, Thomas Müller, Jörg-Uwe Deuker, Iris Schrader, Dirk Strumberg, Christoph Uleer, Erich‐Franz Solomayer, Ingo B. Runnebaum, Hartmut Link, O. Tomé, Hans-Ullrich Ulmer, Bettina Conrad, Gabriele Feisel-Schwickardi, Holger Eidtmann, Claudia Schumacher, T. Steinmetz, Ingo Bauerfeind, Stephan Kremers, D Langanke, U. Kullmer, Angelika Ober, Dorothea Fischer, A. Kohls, W. Weikel, Joachim Bischoff, Kristin Freese, Marcus Schmidt, W. Wiest

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: